Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Titan Pharma (TTNP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Thinking about buying stock in Advanced Micro Devices, General Electric, China Internet Nationwide, Spark Therapeutics or Titan Pharmaceuticals?

InvestorsObserver issues critical PriceWatch Alerts for AMD, CIFS, GE, ONCE, and TTNP.

ONCE : 113.96 (+0.33%)
TTNP : 1.76 (-1.12%)
AMD : 23.25 (-0.17%)
CIFS : 3.01 (+9.06%)
GE : 10.20 (+2.41%)
Titan Pharmaceuticals Partners With AllianceRx Walgreens Prime Specialty Pharmacy To Expand Patient Access To Probuphine®

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) today announced the execution of a specialty pharmacy distribution and services agreement with AllianceRx Walgreens Prime that will expand patient access to treatment...

TTNP : 1.76 (-1.12%)
Titan Pharmaceuticals Selects Life Sciences Business Intelligence CRM Innovator, TikaMobile, to Empower its Sales and MSL Teams

TikaMobile, a premier cloud-based business intelligence CRM provider for the life sciences industry, today announced that Titan Pharmaceuticals, Inc. has selected Tika's BI/CRM platform to deliver real-time,...

TTNP : 1.76 (-1.12%)
Cancer Drug Development Shows That Government and Private Sector can Work Together

Considering that yesterday, February 4, was World Cancer Day, it is encouraging that the private sector and the U.S. government are mutually trying to solve a serious problem and are in fact, working closely...

EOLS : 23.85 (-3.95%)
AGEN : 2.88 (+0.35%)
TTNP : 1.76 (-1.12%)
QGEN : 39.69 (-0.38%)
MBRX : 1.25 (-1.57%)
4 Healthcare Stocks Looking To Start February Off Strong

CORAL GABLES, FL / ACCESSWIRE / February 1, 2019 / The market's success is largely dependent on the fact that, as the global population increases, more people will fall prey to illnesses and ailments,...

TTNP : 1.76 (-1.12%)
PHGI.CN : 0.760 (+1.33%)
ALRN : 2.08 (+9.47%)
PHGRF : 0.5520 (-3.93%)
ENOB : 6.82 (-2.43%)
Pipeline Update, Review and Progress Titan Pharmaceuticals, Inc.

NEW YORK, NY / ACCESSWIRE / February 1, 2019 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive...

TTNP : 1.76 (-1.12%)
Titan Pharmaceuticals Reports Positive Initial Results Of Probuphine® Relaunch

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), today provided an update on the U.S. commercial relaunch of Probuphine (buprenorphine) implant, its unique six-month treatment for Opioid Use Disorder (OUD)....

TTNP : 1.76 (-1.12%)
Titan Pharmaceuticals Announces Reverse Stock Split

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a commercial stage company developing proprietary therapeutics using its ProNeura(TM) long-term continuous drug delivery technology, announced today that it...

TTNP : 1.76 (-1.12%)
Biotech Stocks Beating the Market

HENDERSON, NV / ACCESSWIRE / December 10, 2018 / Here are several biotech plays to pay close attention to in the coming sessions.

CRON : 21.69 (+3.29%)
TTNP : 1.76 (-1.12%)
CLVS : 27.48 (+0.15%)
MNKD : 2.15 (-2.27%)
Alternatives to Watch

HENDERSON, NV / ACCESSWIRE / December 10, 2018 / Below are several companies positioning themselves to be a viable opioid alternative.

CARA : 19.06 (+3.76%)
COLL : 17.59 (+3.59%)
TTNP : 1.76 (-1.12%)
INSY : 4.39 (+6.04%)
ENDV : 0.0186 (-11.43%)
Titan Pharmaceuticals: 3Q Earnings Snapshot

SAN FRANCISCO (AP) _ Titan Pharmaceuticals Inc. (TTNP) on Wednesday reported a loss of $2 million in its third quarter.

TTNP : 1.76 (-1.12%)
Titan Pharmaceuticals Reports Third Quarter 2018 Financial Results

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a company developing and commercializing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura(TM) long-term, continuous...

TTNP : 1.76 (-1.12%)
Titan Pharmaceuticals Schedules Conference Call To Review Third Quarter 2018 Financial Results

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP), a company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura(TM) long-term, continuous drug delivery technology,...

TTNP : 1.76 (-1.12%)
Titan Pharmaceuticals: 1Q Earnings Snapshot

SAN FRANCISCO (AP) _ Titan Pharmaceuticals Inc. (TTNP) on Tuesday reported a loss of $2.6 million in its first quarter.

TTNP : 1.76 (-1.12%)
Titan Pharmaceuticals Reports First Quarter 2018 Financial Results

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura(TM) long-term, continuous drug delivery technology,...

TTNP : 1.76 (-1.12%)
Titan Pharmaceuticals To Report First Quarter 2018 Financial Results On May 15, 2018

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP), a company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura(TM) long-term, continuous drug delivery technology,...

TTNP : 1.76 (-1.12%)
Titan Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / April 2, 2018 / Titan Pharmaceuticals, Inc. (NASDAQ: ) will be discussing their earnings results in their Q4 Earnings Call to be held on April 2, 2018 at 4:15 PM Eastern Time....

TTNP : 1.76 (-1.12%)
Titan Pharmaceuticals reports 4Q loss

SAN FRANCISCO (AP) _ Titan Pharmaceuticals Inc. (TTNP) on Monday reported a loss of $3.7 million in its fourth quarter.

TTNP : 1.76 (-1.12%)
Titan Pharmaceuticals Reports Fourth Quarter And Full Year 2017 Financial Results

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura(TM) long-term, continuous drug delivery technology,...

TTNP : 1.76 (-1.12%)
Titan Pharmaceuticals Schedules Conference Call To Review Fourth Quarter And Full Year 2017 Financial Results

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP), a company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura(TM) long-term, continuous drug delivery technology,...

TTNP : 1.76 (-1.12%)

Van Meerten Stock Picks

Trilogy Metals - Pick of the Day
My Stock Pick of the Day belongs metal mining company Trilogy Metals(TMQ).
TMQ +0.02
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar